Finding flexibility in a resource limited world: Online presentation

Time and resource optimization are top-of-mind for many clinical labs working with NGS. As a resource for clinical researchers and labs, we revisit this presentation on panel evaluation.

In this presentation, Cynthia Schandl, MD, PhD and Julie Hirschhorn, PhD evaluate the flexibility, affordability, and ease-of-use of different solid tumor and myeloid panels for NGS testing.

Description
While there are multiple advantages to implementing NGS in the clinical lab, NGS testing has the potential to be both time and resource consuming. Cynthia Schandl, MD, PhD and Julie Hirschhorn, PhD of the Medical University of South Carolina will discuss their process for selection of solid tumor and myeloid panels for evaluation. While keeping clinical relevance in mind, the selection process involved assessing assays for flexibility, affordability, and ease-of-use. This presentation will include an evaluation and discussion of the single-tube Stem-Loop Inhibition Mediated Amplification (SLIMamp®) technology from Pillar Biosciences for detection of variants in solid and myeloid tumors.

Don’t Stop Here

More To Explore

This small academic lab ramped up in-house NGS testing despite limited resources, and you can too

“There has been sort of this push to make genomics a send-out endeavor…and we are pushing back.” Dr. Cynthia Schandl is the director of a …

Read More →

Pillar Biosciences Closes $29.7 Million in Series C Financing

Financing to Advance IVD and RUO Product Development and to Expand Global Commercialization Natick, MA, May 5, 2020—Pillar Biosciences, an NGS clinical cancer diagnostics company, …

Read More →

Finding flexibility in a resource limited world: Online presentation

Time and resource optimization are top-of-mind for many clinical labs working with NGS. As a resource for clinical researchers and labs, we revisit this presentation …

Read More →
Four people smile out of the screen from their lab stations.

The complexity of the NGS process, compounded by sample processing, results in unique challenges for clinical oncology laboratories

Increasingly, clinical samples of all types are being analyzed with the goal of matching patients to target therapies. In the summer of 2017, Thermo Fisher received …

Read More →
Top 5 reasons to go custom with Pillar Biosciences in graphic font

5 reasons to go custom with your next sequencing panel

Off-the-shelf next-generation sequencing (NGS) panels save on sequencing costs by targeting specific genes, and the smaller resulting datasets are easier to analyze. The catch is, …

Read More →
a graphic that reads "Garbage in, Greatness out" next to a photo of a tumor sample embedded in parafin wax for analysis

Garbage in, greatness out: making the most of FFPE samples

The cancer research community relies on formalin-fixed samples, but the quality of these samples degrades over time. Sequencing data from partially degraded samples is plagued …

Read More →
WP Feedback

Dive straight into the feedback!
Login below and you can start commenting using your own user instantly

Scroll to Top